Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What's Old Is New-Reference-Cited by-同舟云学术

Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What's Old Is New

Published:2015-10 Issue:5 Volume:15 Page:e277-e285
ISSN:1526-8209
Container-title:Clinical Breast Cancer
language:en
Short-container-title:Clinical Breast Cancer

Author:

Cho Eunpi^ORCID,Schwemm Ann K.,Rubinstein Lena M.,Stevenson Philip A.,Gooley Ted A.,Ellis Georgiana K.,Specht Jennifer M.,Livingston Robert B.,Linden Hannah M.,Gadi Vijayakrishna K.

Funder

NCRR/NIH

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Combination chemotherapy as an adjuvant treatment in operable breast cancer;Bonadonna;N Engl J Med,1976

2. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up;Bonadonna;N Engl J Med,1995

3. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study;Mansour;N Engl J Med,1989

4. Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study;Rivkin;J Clin Oncol,1989

5. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer;Harvey;J Clin Oncol,1999

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Retrospective Analysis of Metronomic Cyclophosphamide, Methotrexate, and Fluorouracil (CMF) Versus Docetaxel and Cyclophosphamide (TC) as Adjuvant Treatment in Early Stage, Hormone Receptor Positive, HER2 Negative Breast Cancer;Clinical Breast Cancer;2021-09

2. Persistent taxane‐induced neuropathy in elderly patients treated for localized breast cancer;The Breast Journal;2020-12

3. Cardiovascular and Central Nervous System Toxicity by Anticancer Drugs in Breast Cancer Patients;Brain and Heart Dynamics;2020

4. Cardiovascular and Central Nervous System Toxicity by Anticancer Drugs in Breast Cancer Patients;Brain and Heart Dynamics;2019-11-08

5. Renal toxicity with liposomal doxorubicin in metastatic breast cancer;Journal of Oncology Pharmacy Practice;2018-08-31